GLYCOBIOLOGY MARKET ANALYSIS

Glycobiology Market, by Product Type (Instruments, Enzymes, Consumables, Reagents & Kits, and Others), by Application (Diagnostic Applications, Industrial Applications, Therapeutic Applications, Drug Discovery and Development, and Others), by End User (Research Laboratories, Hospitals, Diagnostic Centers, Biopharmaceutical Companies, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

Published In : Oct 2022
Code : CMI3639
Pages :195
Formats :
Excel and PDF
Industry : Biotechnology

Market News

Global Glycobiology Market: Key Developments

In January, 2022, the Iceni Glycoscience, a company with expertise in glycoscience (carbohydrate chemistry and biology), launched a new in-house research and drug development program focused on glycoscience and glycoengineering.

In July, 2022, Ludger, a company conducting research and development in glyco technology, announced the pre-launch of three Lewis X glycan standards CN-A2G2F2-20U, CN-A2[3]G1F1-20U, CN-A2[3]G1-20U. Lewis X (Lex) is a fucosylated trisaccharide glycan epitope distributed in eukaryotes and certain bacteria. This carbohydrate epitope has been found to play a role in many physiological and pathological processes such as pathogenesis of diseases. Carbohydrate epitope is up regulated in various cancers such as pancreatic, breast, colon, and lung tumors, plays an important role in cell-cell interactions, and has been found in infectious bacteria such as Helicobacter pylori.